Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future?

Gelijkaardige items

• Active surveillance for prostate cancer
  door: Shill, Daniela K., et al.
  Gepubliceerd in: (2021)
• Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer
  door: Beckmann, Kerri, et al.
  Gepubliceerd in: (2021)
• Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function—a retrospective study in low-risk prostate cancer patients
  door: Crump, R. Trafford, et al.
  Gepubliceerd in: (2021)
• The need for research methodology to improve acceptability of long-term surveillance for cancer
  door: Kinsella, Netty, et al.
  Gepubliceerd in: (2021)
• Expectant management in genitourinary malignancies (prostate, bladder, kidney)
  door: Van Hemelrijck, Mieke, et al.
  Gepubliceerd in: (2021)